Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel nanomedicines to overcome cancer multidrug resistance
Zhenwei Su, Shaowei Dong, Shan‐Chao Zhao, et al.
Drug Resistance Updates (2021) Vol. 58, pp. 100777-100777
Closed Access | Times Cited: 137

Showing 26-50 of 137 citing articles:

Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance
Jianing Gong, Taoran Shi, Jinfeng Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114505-114505
Open Access | Times Cited: 25
Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy
Y. Qin, Shisong Han, Yahan Yu, et al.
Liver International (2024) Vol. 44, Iss. 8, pp. 1808-1831
Closed Access | Times Cited: 14
Targeting anoikis resistance as a strategy for cancer therapy
Yumin Wang, Sihang Cheng, Joshua S. Fleishman, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101099-101099
Closed Access | Times Cited: 13
Photodynamically Tumor Vessel Destruction Amplified Tumor Targeting of Nanoparticles for Efficient Chemotherapy
Peipei Yang, Yunxue Xu, Xin Zhi, et al.
ACS Nano (2024) Vol. 18, Iss. 20, pp. 12933-12944
Closed Access | Times Cited: 12
Amorphous metal–organic frameworks: Pioneering frontiers in cancer diagnostics and therapeutics
Jingqi Zhao, Yaowen Zhang, Yankun Luo, et al.
Chemical Engineering Journal (2024) Vol. 492, pp. 152295-152295
Open Access | Times Cited: 11
Nanotherapeutics for prostate cancer treatment: A comprehensive review
Ruimin Hu, Lan Jin, Dinglin Zhang, et al.
Biomaterials (2024) Vol. 305, pp. 122469-122469
Closed Access | Times Cited: 10
Carrier capability of halloysite nanotubes for the intracellular delivery of antisense PNA targeting mRNA of neuroglobin gene
Andrea Patrizia Falanga, Marina Massaro, Nicola Borbone, et al.
Journal of Colloid and Interface Science (2024) Vol. 663, pp. 9-20
Open Access | Times Cited: 9
Deformable Smart DNA Nanomachine for Synergistic Intracellular Cancer‐Related miRNAs Imaging and Chemo‐Gene Therapy of Drug‐Resistant Tumors
Dong Chen, Ye‐Ran Wang, Zhilong Chen, et al.
Small (2024) Vol. 20, Iss. 30
Closed Access | Times Cited: 8
Advances in Pure Drug Self-Assembled Nanosystems: A Novel Strategy for Combined Cancer Therapy
Runyan Niu, Xuexue Liu, Xian Yang, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 68-68
Open Access | Times Cited: 1
A multistage drug delivery approach for colorectal primary tumors and lymph node metastases
Yihang Yuan, Quanjun Lin, Hai‐Yi Feng, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Molecular Modeling Strategies of Cancer Multidrug Resistance
Gözde Yalçın
Drug Resistance Updates (2021) Vol. 59, pp. 100789-100789
Closed Access | Times Cited: 46
Nanoparticles Loaded with Docetaxel and Resveratrol as an Advanced Tool for Cancer Therapy
Magdalena Jurczyk, Janusz Kasperczyk, Dorota Wrześniok, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1187-1187
Open Access | Times Cited: 35
Different mechanisms of drug resistance to hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukemia
Kristína Šimoničová, Ľuboš Janotka, Helena Kavcová, et al.
Drug Resistance Updates (2022) Vol. 61, pp. 100805-100805
Closed Access | Times Cited: 33
Mesoporous silicas in materials engineering: Nanodevices for bionanotechnologies
Elisabetta Mazzotta, Marzia De Santo, Domenico Lombardo, et al.
Materials Today Bio (2022) Vol. 17, pp. 100472-100472
Open Access | Times Cited: 33
Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance
Mjriam Capula, Macarena Perán, Geng Xu, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100864-100864
Open Access | Times Cited: 32
Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy
Wenjing Xu, Chunping Ye, Qing Xin, et al.
Materials Today Bio (2022) Vol. 16, pp. 100358-100358
Open Access | Times Cited: 29
Network biology and artificial intelligence drive the understanding of the multidrug resistance phenotype in cancer
Beatriz Bueschbell, Ana B. Caniceiro, Pedro M. S. Suzano, et al.
Drug Resistance Updates (2022) Vol. 60, pp. 100811-100811
Open Access | Times Cited: 28
Recent Advances in Photothermal Therapy at Near‐Infrared‐II Based on 2D MXenes
Nan Li, Yisen Wang, Yang Li, et al.
Small (2023) Vol. 20, Iss. 6
Open Access | Times Cited: 22
A review of chitosan in gene therapy: Developments and challenges
Liang Dong, Yanan Li, Hailin Cong, et al.
Carbohydrate Polymers (2023) Vol. 324, pp. 121562-121562
Closed Access | Times Cited: 22
Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2
Chung‐Pu Wu, Sung-Han Hsiao, Yu‐Shan Wu
Drug Resistance Updates (2023) Vol. 71, pp. 101011-101011
Closed Access | Times Cited: 21
Sonocatalytic Optimization of Titanium‐Based Therapeutic Nanomedicine
Rui-Rui Zhou, Meiqi Chang, Mengjun Shen, et al.
Advanced Science (2023) Vol. 10, Iss. 25
Open Access | Times Cited: 20
NIR Activated Multimodal Therapeutics Based on Metal–Phenolic Networks‐Functionalized Nanoplatform for Combating against Multidrug Resistance and Metastasis
Cheng Chen, Weixi Jiang, Yuanli Luo, et al.
Small (2023) Vol. 19, Iss. 14
Closed Access | Times Cited: 19
Nanomedicines for Overcoming Cancer Drug Resistance
Tingting Hu, Hanlin Gong, Jiayue Xu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1606-1606
Open Access | Times Cited: 27
Cancer Metastasis and Treatment Resistance: Mechanistic Insights and Therapeutic Targeting of Cancer Stem Cells and the Tumor Microenvironment
Ethan J. Kilmister, Sabrina P. Koh, Freya R. Weth, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2988-2988
Open Access | Times Cited: 25
Co-Delivery of 5-Fluorouracil and Paclitaxel in Mitochondria-Targeted KLA-Modified Liposomes to Improve Triple-Negative Breast Cancer Treatment
Tianyu Chen, Hui Chen, Yichun Jiang, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 881-881
Open Access | Times Cited: 23

Scroll to top